Bristol-myers squibb, lenalidomide (revlimid) 20MG cap 14 doses

Ended Awarded Last action

Contract number
15B50526F00000152
Awardee
Awarding agency
Obligated
$11,319

Award facts

Contract value 100% obligated
$11,319.28 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
Q517 Pharmacy Services
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Princeton, NJ 08543, USA

Award details come from SAM.gov/FPDS.

About this award

Bristol-Myers Squibb Company received a delivery order valued at $11.3K from the Department of Veterans Affairs (VA) through the Pharmaceuticals and Drugs Federal Supply Schedule contract. This firm fixed-price delivery order, issued February 1, 2026, procures 14 doses of Revlimid (lenalidomide) 20mg capsules for delivery by February 28, 2026. The order supports the VA's healthcare mission by supplying advanced oncology pharmaceutical therapies to eligible veterans. No small business set-aside was applied to this award.

This delivery order is issued under Bristol-Myers Squibb's Federal Supply Schedule contract (36F79724D0101) with the VA, a comprehensive multiple-award indefinite delivery/indefinite quantity vehicle with a substantial ceiling of approximately $12.3 billion extending through April 30, 2029. Bristol-Myers Squibb, a global biopharmaceutical manufacturer headquartered in Lawrenceville, New Jersey, has been a critical federal contractor since 2006, specializing in oncology, immunotherapy, and cell therapy products. The VA has issued more than 50 delivery orders to Bristol-Myers Squibb since 2022, predominantly supporting Veterans Integrated Service Network 9, reflecting sustained demand for the company's specialized cancer treatments that represent current standards of care in oncology across the Veterans Health Administration network.

Quick answers

Who was awarded contract 15B50526F00000152?

15B50526F00000152 was awarded to Bristol-Myers Squibb Company by Federal Medical Center Carswell (Correctional Facilities) on February 1, 2026.

How much is contract 15B50526F00000152 worth?

The government has obligated $11,319 on 15B50526F00000152.

Is contract 15B50526F00000152 an order under another contract?

Yes. 15B50526F00000152 is a delivery order under 36F79724D0101, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 15B50526F00000152 competed?

The extent of competition for 15B50526F00000152 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award